• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET/CT 分期在早期口咽鳞癌中的阴性预测价值及其对经口机器人手术患者选择的影响。

The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.

机构信息

Department of Head and Neck Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

Department of Head and Neck Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Department of ENT Head & Neck Surgery, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia.

出版信息

Oral Oncol. 2022 Dec;135:106213. doi: 10.1016/j.oraloncology.2022.106213. Epub 2022 Oct 20.

DOI:10.1016/j.oraloncology.2022.106213
PMID:36274346
Abstract

OBJECTIVES

Our objective was to determine the negative predictive value (NPV) of preoperative FDG PET/CTfor detecting locoregional nodal disease. The aim was to help inform the decision-making process when identifying patients with early-stage OPSCC that would be suitable for transoral robotic surgery (TORS) as a single-modality treatment.

MATERIALS AND METHODS

A retrospective cohort study was conducted of adults with primary stage cT1-2 OPSCC with up to one metastatic neck lymph node (cN0-1) planned for TORS. Patients with a preoperative PET/CT and who had undergone staging neck dissection (ND) were included. Clinical and pathological nodal staging was established based on PET/CT and ND, respectively. The primary outcome was the frequency of occult (not seen on PET/CT) nodal disease on ND.

RESULTS

Eighty-eight patients were included (N = 88). The rate of occult nodal disease was 28.4 % (n = 25). The NPV of PET/CT in the clinically negative neck was 79 % and 66 % in cases with a single clinical node. Following staging ND, thetreatment plan changed in 27 % of cases overall, 7 % in cN0 and 36.7 % in cN1. Among these, 18 % met criteria for radiotherapy and 9 % for CRT. This represented a decrease in the number of ideal candidates for TORS as single-modality treatment from 88 to 64 (73 %).

CONCLUSIONS

PET/CT is a useful tool in the workup of patients for primary TORS. However, about one third of patients with early-stage OPSCC might benefit from adjuvant therapy not predicted by preoperative PET/CT. A staging ND helps confirm candidates for single-modality treatment with TORS.

摘要

目的

我们的目的是确定术前 FDG PET/CT 检测局部区域淋巴结疾病的阴性预测值(NPV)。目的是帮助在确定适合经口机器人手术(TORS)作为单一模式治疗的早期 OPSCC 患者时,为决策过程提供信息。

材料和方法

对计划接受 TORS 的原发性 cT1-2 OPSCC 伴最多一个转移性颈部淋巴结(cN0-1)的成人进行了回顾性队列研究。纳入了术前 PET/CT 检查并接受了分期颈部清扫术(ND)的患者。临床和病理淋巴结分期分别基于 PET/CT 和 ND 确定。主要结局是 ND 上隐匿性(PET/CT 未见)淋巴结疾病的频率。

结果

共纳入 88 例患者(N=88)。隐匿性淋巴结疾病的发生率为 28.4%(n=25)。临床阴性颈部的 PET/CT 的 NPV 为 79%,单一临床淋巴结的 NPV 为 66%。在接受分期 ND 后,总体治疗计划发生改变的病例占 27%,cN0 占 7%,cN1 占 36.7%。其中,18%符合放疗标准,9%符合 CRT 标准。这意味着作为单一模式治疗的理想 TORS 候选人数从 88 人减少到 64 人(73%)。

结论

PET/CT 是原发性 TORS 患者检查的有用工具。然而,大约三分之一的早期 OPSCC 患者可能受益于术前 PET/CT 未预测的辅助治疗。分期 ND 有助于确认适合 TORS 单一模式治疗的候选者。

相似文献

1
The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.18F-FDG PET/CT 分期在早期口咽鳞癌中的阴性预测价值及其对经口机器人手术患者选择的影响。
Oral Oncol. 2022 Dec;135:106213. doi: 10.1016/j.oraloncology.2022.106213. Epub 2022 Oct 20.
2
Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.2013 年至 2020 年连续单机构研究:低辅助治疗率的早期口咽鳞状细胞癌经口机器人手术治疗的结果。
Oral Oncol. 2024 May;152:106783. doi: 10.1016/j.oraloncology.2024.106783. Epub 2024 Apr 2.
3
Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.原发肿瘤切除术联合双侧颈淋巴结清扫术治疗口咽鳞癌患者隐匿性对侧颈部淋巴结转移。
Oral Oncol. 2019 Jun;93:96-100. doi: 10.1016/j.oraloncology.2019.04.017. Epub 2019 May 1.
4
Evaluating contralateral neck failure in patients with lateralized OPSCC treated with transoral robotic surgery and neck management based on pre-operative SPECT-CT lymphatic mapping.评估经口机器人手术和基于术前 SPECT-CT 淋巴定位的颈管理治疗的侧化 OPSCC 患者的对侧颈部失败。
J Otolaryngol Head Neck Surg. 2022 Dec 27;51(1):47. doi: 10.1186/s40463-022-00563-z.
5
Positron emission tomography/computed tomography after primary transoral robotic surgery for oropharyngeal squamous cell carcinoma.口咽鳞状细胞癌初次经口机器人手术后的正电子发射断层扫描/计算机断层扫描
Laryngoscope. 2017 Sep;127(9):2050-2056. doi: 10.1002/lary.26515. Epub 2017 Mar 8.
6
PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.PET/CT 对 HPV 相关口咽癌第 8 版 AJCC 病理分期的预测效果不佳。
Laryngoscope. 2021 Jul;131(7):1535-1541. doi: 10.1002/lary.29366. Epub 2021 Jan 11.
7
Utility of PET-CT in Newly Diagnosed HPV-Associated Oropharyngeal Squamous Cell Carcinoma.PET-CT 在新诊断的 HPV 相关口咽鳞状细胞癌中的应用。
Ann Otol Rhinol Laryngol. 2023 Oct;132(10):1133-1139. doi: 10.1177/00034894221135934. Epub 2022 Dec 1.
8
Utility of up-front transoral robotic surgery in tailoring adjuvant therapy. upfront经口机器人手术在定制辅助治疗中的应用价值。
Head Neck. 2016 Aug;38(8):1201-7. doi: 10.1002/hed.24390. Epub 2016 May 26.
9
Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.丹麦头颈癌中心开展的早期口咽鳞状细胞癌同期颈部清扫的原发性经口机器人手术:一项关于可行性和肿瘤切缘状态的II期试验
Eur Arch Otorhinolaryngol. 2017 May;274(5):2229-2237. doi: 10.1007/s00405-016-4433-3. Epub 2017 Jan 3.
10
Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.经口机器人手术(TORS)与非机器人内镜手术治疗口咽癌的切缘与生存率比较。
Am J Otolaryngol. 2023 Nov-Dec;44(6):103982. doi: 10.1016/j.amjoto.2023.103982. Epub 2023 Jul 6.